Byrl Medical India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 44.32%
- Profit Growth 113.63%
- Ebitda 117.96%
- Net Worth 67.01%
- Total Assets 53.65%
About Byrl Medical India
Byrl Medical India Private Limited (BMIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 05 October 2009 and has a history of 15 years and four months. Its registered office is in South Delhi, Delhi, India.
The Corporate was formerly known as Lina Medical India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Jain and Akanksha Jain serve as directors at the Company.
Company Details
-
Location
South Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2009FTC194904
-
Company No.
194904
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
05 Oct 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Byrl Medical India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Jain
|
Director | 24-Nov-2011 | Current |
|
Akanksha Jain
|
Director | 12-Feb-2018 | Current |
Financial Performance of Byrl Medical India.
Byrl Medical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.32% increase. The company also saw a substantial improvement in profitability, with a 113.63% increase in profit. The company's net worth Soared by an impressive increase of 67.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Byrl Medical India?
In 2023, Byrl Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Byrl Bioceuticals India Private LimitedAkanksha Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Byrl Medical India?
Unlock and access historical data on people associated with Byrl Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Byrl Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Byrl Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
